Mary Anne Dooley, M.D., MPH
Associate Professor
Phone: (919) 966-4191
Fax: (919) 966-4251
Office Location:
Thurston Arthritis
Research Center

Specialty Areas: Lupus Nephritis

Chronology: B.S., Yale University, 1979
M.D., University of North Carolina at Chapel Hill, 1983, M.P.H., University of North Carolina at Chapel Hill, 1985

Dr. Dooley's research interests lie in the area of clinical investigation and outcomes reserach in systemic lupus erythematosus, with publications focusing on environmental and hormonal risks and outcomes for lupus and lupus nephritis.

Selected Bibliography:

Bernatsky S, Boivin JF, Jospeh L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R.  Mortality in systemic lupus erythematosus.  Arthritis Rheum.  2006 54:2550-2557.

Dooley MA.  Mycophenylate mofetil: what role in the treatment of lupus? Lupus. 2006 15:179-82.

Gardner J, Steinsson K, Australie K, Manzi S, Ginzler E, Urowitz M, Gladman D, S Edworthy, Senecal JL, Zummer M, Ensworth S, Pope J, El-Gabalaway H, St Pierre Y, Dooley MA, Ramsey-Goldman R, Zoma A, Aaranow C. Race/ethnicity and cancer occurrence in systemic lupus erythematosus.  Arthritis Rheum.  2005 53:781-4.

Blalock SJ, Norton LL, Patel RA, Dooley MA.  Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.  Arthritis Rheum.  2005 Oct 15;53(5):732-9.

Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St. Clair EW, Gilkeson GS, and Pandey JP.  Association of Epstein-Barr virus and systemic lupus erythematosus: effect modification by race, age and CTLA-4 genotype. Arthritis Rheum.  2005 Apr;52:1148-59.

Click here for a list of publications on PubMed.


Back to Faculty & Staff Profiles Page